Cdk5-dependent regulation of glucose-stimulated insulin secretion
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complications. Present treatments to reduce hyperglycemia mainly target the ATP-sensitive K(+) (K(ATP)) channel of pancreatic beta cells to increase insulin secretion. These current approaches are often associated with the side effect of hypoglycemia. Here we show that inhibition of the activity of cyclin-dependent kinase 5 (Cdk5) enhanced insulin secretion under conditions of stimulation by high glucose but not low glucose in MIN6 cells and pancreatic islets. The role of Cdk5 in regulation of insulin secretion was confirmed in pancreatic beta cells deficient in p35, an activator of Cdk5. p35-knockout mice also showed enhanced insulin secretion in response to a glucose challenge. Cdk5 kinase inhibition enhanced the inward whole-cell Ca(2+) channel current and increased Ca(2+) influx across the L-type voltage-dependent Ca(2+) channel (L-VDCC) upon stimulation with high glucose in beta cells, but had no effect on Ca(2+) influx without glucose stimulation. The inhibitory regulation by Cdk5 on the L-VDCC was attributed to the phosphorylation of loop II-III of the alpha(1C) subunit of L-VDCC at Ser783, which prevented the binding to SNARE proteins and subsequently resulted in a decrease of the activity of L-VDCC. These results suggest that Cdk5/p35 may be a drug target for the regulation of glucose-stimulated insulin secretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CDK5 has been implicated in the regulation of pancreatic beta cell function, through formation of p35/CDK5 complexes that downregulate insulin expression (11, 12).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [12]
Citations
Cites
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,008 · cited 1×
“dtd" [ ]> Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complication”
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., & Tsai, L.-H. (1997) · Neuron · doi:10.1016/s0896-6273(01)80044-1 · Cited by 715 · cited 1×
“We further investigated Ca 2+ influx in beta cells isolated from p35-knockout mice, in which Cdk5 kinase activity is extremely lo”
BackgroundInhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
A brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., & Wang, J. H. (1994) · Nature · doi:10.1038/371423a0 · Cited by 579
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
Tsai, L.-H., Takahashi, T., Caviness, V. S., & Harlow, E. (1993) · Development · doi:10.1242/dev.119.4.1029 · Cited by 457
An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) Activator
Tang, D., Yeung, J., Lee, K.-Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., & Wang, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26897 · Cited by 340
Self-citationTriggering and Augmentation Mechanisms, Granule Pools, and Biphasic Insulin Secretion
Bratanova-Tochkova, T. K., Cheng, H., Daniel, S., Gunawardana, S., Liu, Y.-J., Mulvaney-Musa, J., Schermerhorn, T., Straub, S. G., Yajima, H., & Sharp, G. W. G. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s83 · Cited by 291 · cited 1×
“The biochemical mechanism of insulin secretion has been studied extensively with the aim of identifying target molecules for the treatment of diabete”
Background
Cited by
Items 101–200 of 202
tRNA modifications and islet function
Wei, F., & Tomizawa, K. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13405 · Cited by 26
Self-citationCdk5/p35 is required for motor coordination and cerebellar plasticity
He, X., Ishizeki, M., Mita, N., Wada, S., Araki, Y., Ogura, H., Abe, M., Yamazaki, M., Sakimura, K., Mikoshiba, K., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12756 · Cited by 24
Self-citationODF1 Phosphorylation by Cdk5/p35 Enhances ODF1-OIP1 Interaction
Rosales, J. L., Sarker, K. P., Ho, N., Broniewska, M., Wong, P., Cheng, M., van der Hoorn, F., & Lee, K. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000107517 · Cited by 22
Li, C., Shen, K., Yang, M., Yang, Y., Tao, W., He, S., Shi, L., Yao, Y., & Li, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s288587 · Cited by 24
Haney, S. A., Zhao, J., Tiwari, S., Eng, K., Guey, L. T., & Tien, E. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064946 · Cited by 25
Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus
Ahmed, D., & Sharma, M. (2011) · International Journal of Endocrinology · doi:10.1155/2011/530274 · Cited by 23
“Hindawi Publishing Corporation International Journal of Endocrinology Volume 2011, Article ID 530274, 10 pages doi:10.1155/2011/530274”
InfluentialHuang, Y., Huang, W., Huang, Y., Song, P., Zhang, M., Zhang, H., Pan, S., & Hu, Y. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191098 · Cited by 22
“Studies showed that such inhibitors affected the eye and the pancreas islet, which may be used for helping detect the safety issues of selective inhibit peptides [30, 51, 52].”
Gene Expression Profiling of a Mouse Model of Pancreatic Islet Dysmorphogenesis
Crawford, L. W., Ables, E. T., Oh, Y. A., Boone, B. E., Levy, S., & GANNON, M. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001611 · Cited by 21
Kozuka, C., Sunagawa, S., Ueda, R., Higa, M., Ohshiro, Y., Tanaka, H., Shimizu‐Okabe, C., Takayama, C., Matsushita, M., Tsutsui, M., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13236 · Cited by 23
“, 1990), was measured as described earlier (Wei et al., 2005).”
MethodSelf-citationHouzé, S., Hoang, N.-T., Lozach, O., Bras, J. L., Meijer, L., Galons, H., & Demange, L. (2014) · Molecules · doi:10.3390/molecules190915237 · Cited by 21
“activities (neuronal survival and migration), development of the cerebral cortex, phosphorylation of tau and production of β-amyloïd, pain signaling and pancreatic secretion of insulin [25,51–53].”
BackgroundLi, J., Li, Q., Tang, J.-S., Xia, F.-Y., Wu, J., & Zeng, R. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00507 · Cited by 21
Cheng, M., Liu, X., Yang, M., Han, L., Xu, A., & Huang, Q. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12421 · Cited by 25
“TheCDKAL1 gene encodes a protein that inhibits activation of CDK5, which has a role in the regulation of insulin secretion.(65,66) Carriers of CDKAL1 risk alleles have a twofold increased risk of developing T2D through impaired insulin secretion.”
BackgroundMiyaki, K., Oo, T. N., Song, Y., Lwin, H., 冨田, 裕., Hoshino, H., Suzuki, N., & Muramatsu, M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq281 · Cited by 24
Cdk5r1 Overexpression Induces Primary β -Cell Proliferation
Draney, C., Hobson, A., Grover, S. G., Jack, B. O., & Tessem, J. S. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6375804 · Cited by 26
Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis
Zheng, Y.-L., Hu, Y., Zhang, A., Wang, W., Li, B., Amin, N. D., Grant, P. G., & Pant, H. C. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.067 · Cited by 20
Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery
Tang, W., Lin, C., Yu, Q., Zhang, D., Liu, Y., Zhang, L., Zhou, Z., Zhang, J., & Ouyang, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00566 · Cited by 19
Liu, W., Liu, S., Liu, Q., Hao, J., Shi, Y., Song, Z., Duan, H., & Zhang, Y. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182648459 · Cited by 19
Li, L., Kołodziej, T., Jafari, N., Chen, J., Zhu, H., Rajfur, Z., & Huang, C. (2018) · The FASEB Journal · doi:10.1096/fj.201800296r · Cited by 19
“It has been reported that Cdk5 negatively regulates insulin secretion (55, 56).”
BackgroundLegøy, T. A., Ghila, L., Vethe, H., Abadpour, S., Mathisen, A. F., Paulo, J. A., Scholz, H., Ræder, H., & Chera, S. (2019) · Acta Physiologica · doi:10.1111/apha.13433 · Cited by 18
Protein Kinase Cζ Regulates Cdk5/p25 Signaling during Myogenesis
de Thonel, A., Ferraris, S. E., Pallari, H., Imanishi, S. Y., Kochin, V., Hosokawa, T., Hisanaga, S., Sahlgren, C., & Eriksson, J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0847 · Cited by 20
Dimri, M., Bilogan, C. K., Pierce, L. X., Naegele, G., Vasanji, A., Gibson, I., McClendon, A., Tae, K., & Sakaguchi, T. F. (2017) · Development · doi:10.1242/dev.147397 · Cited by 18
“While Cdk5 has been intensively studied in the context of neural development, several studies have begun to hint at an important role outside the nervous system (Dhavan and Tsai, 2001; Na et al., 2015; Wei et al., 2005).”
BackgroundKatsube, H., Hinami, Y., Yamazoe, T., & Inoue, Y. H. (2019) · Biology Open · doi:10.1242/bio.046524 · Cited by 18
“CDK5 is an atypical cyclin-dependent kinase functioning in differentiated post-mitotic cells, such as neurons, and pancreatic β-islet cells (Tsai et al., 1994; Connell-Crowley et al., 2000; Wei et al., 2005; Choi et al., 2010; Kang et al., 2012).”
BackgroundMartin, D. J., Allagnat, F., Gesina, E., Caille, D., Gjinovci, A., Waeber, G., Meda, P., & Haefliger, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045844 · Cited by 17
Polis, B., Squillario, M., Gurevich, V., Srikanth, K. D., Assa, M., & Samson, A. O. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03519-3 · Cited by 16
“Its inhibition improves the inward whole-cell Ca2+ channel current and enhances insulin secretion [76].”
BackgroundSeedat, F., Holden, K. L., Davis, S. A., Fischer, R., Bancroft, J. M., Drydale, E., Kandžija, N., Todd, J. A., Vatish, M., & Stefana, M. I. (2025) · Nature Communications · doi:10.1038/s41467-025-61852-5 · Cited by 15
“CDK5 enhances β -cell survival and proliferation, regulates insulin gene transcription, promotes insulin secretion, and protects β cells 42 – 46 .”
Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsy
Dixit, A. B., Banerjee, J., Tripathi, M., Sarkar, C., & Chandra, P. S. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1249_14 · Cited by 20
Li, Y., Xiang, Q., Yao, Y.-H., Li, J., Wang, Y., & Li, X.-H. (2019) · Biochimie · doi:10.1016/j.biochi.2019.11.010 · Cited by 14
Sdao, S. M., Ho, T., Poudel, C., Foster, H. R., Leon, E. R. D., Adams, M. T., Lee, J.-H., Blum, B., Rane, S. G., & Merrins, M. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108690 · Cited by 15
“In addition to CDK2, CDK1 (Gregg et al., 2019), CDK5 (Wei et al., 2005), and CDK8 (Xue et al., 2019) have been found to regulate glucose-stimulated insulin secretion.”
Saha, D., Paul, S. C., Gaharwar, U., Priya, A., Neog, A., Singh, A., & Binukumar, B. K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00341 · Cited by 16
Yu, X., Song, L., Wei, S., Wen, X., & Liu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.722674 · Cited by 14
“CDK5 has been suggested to downregulate insulin secretion through the formation of p35/ CDK5 complexes (13, 14).”
BackgroundAssociation of the CDKAL1 polymorphism rs10946398 with type 2 diabetes mellitus in adults
Liu, X., Liang, J., Geng, H., Xu, W. G., Teng, F., & Yang, M. (2020) · Medicine · doi:10.1097/md.0000000000021383 · Cited by 13
“CDK5 reduces insulin secretion in response to glucose; additionally, it has a permissive role in the decrease of insulin gene expression that results from glucotoxicity as well as in the pathophysiology of b-cell dysfunction and predisposition to type 2 diabetes.([25,26]) This review had a few limitations.”
BackgroundFrequent Loss of Genome Gap Region in 4p16.3 Subtelomere in Early-Onset Type 2 Diabetes Mellitus
Kudo, H., Emi, M., Ishigaki, Y., Tsunoda, U., Hinokio, Y., Ishii, M., Sato, H., Yamada, T., Katagiri, H., & Oka, Y. (2011) · Experimental Diabetes Research · doi:10.1155/2011/498460 · Cited by 17
“Genes involved in the glucose-induced insulin secretion cascade of pancreatic beta-cells are located in the region, such as ATP5I (ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E) [42, 43], CPLX1 (complexin 1) [44, 45], GAK (cyclin G associated kinase) in association with CDK5 (cyclin-dependent prot…”
BackgroundGenetics of Gestational Diabetes Mellitus
Kwak, S. H., Jang, H. C., & Park, K. S. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.7.688 · Cited by 13
Kim, A. N., Cho, H. J., Youn, J., Jin, T., Kang, M.-I., Sung, J., & Lee, J. E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155379 · Cited by 13
“Since CDK5 is implicated in insulin secretion in pancreatic β-cells, CDKAL1 may regulate insulin secretion through interaction with CDK5 [41,43].”
BackgroundPark, S. J., Yang, S. W., & Kim, B.-C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.121 · Cited by 12
Tuerxunyiming, M., Mohemaiti, P., Wufuer, H., & Tuheti, A. (2015) · PubMed Central · Cited by 12
Ripperger, J. A., Chavan, R., Albrecht, U., & Brenna, A. (2022) · Clocks & Sleep · doi:10.3390/clockssleep4010017 · Cited by 14
“However, many observations indicated that CDK5 could play a pivotal role also outside the brain, such as in pancreatic β-cells [36], adipose tissue [37], ovary cells [38], and the male reproductive system [39,40].”
BackgroundZebrafish Rohon-Beard Neuron Development: Cdk5 in the Midst
Kanungo, J., Zheng, Y.-L., Mishra, B., & Pant, H. C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9885-4 · Cited by 12
“P39mediated cdk5 activation seems to positively regulate glucose-dependent insulin secretion, but p35-mediated cdk5 activation seems to negatively regulate glucosedependent insulin secretion [99–101].”
BackgroundPhotoreactivity of indirubin derivatives
Olivier, D., Poincelot, M.-A., Douillard, S., Lefevre, C., Moureau, J., Ferandin, Y., Bettayeb, K., Xiao, Z., Magiatis, P., Skaltsounis, A., et al. (2008) · Photochemical & Photobiological Sciences · doi:10.1039/b711261k · Cited by 11
Vera, D. M., López-Gambero, A. J., Navarro, J. A., Sanjuan, C., Baixerás, E., Decara, J. M., & de Fonseca, F. R. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379015 · Cited by 12
Translational implications of the β-cell epigenome in diabetes mellitus
Johnson, J. S., & Evans‐Molina, C. (2014) · Translational research · doi:10.1016/j.trsl.2014.03.002 · Cited by 10
“CDK5 is activated in the β cell by high glucose and the pro-inflammatory cytokine interleukin 1β (47).”
Verma, A. K., Beg, M. M. A., Khan, N. A., Goyal, Y., Dev, K., & Joshi, P. C. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100767 · Cited by 10
Development of type 2 diabetes caused by a deficiency of a tRNAlysmodification
Wei, F., & Tomizawa, K. (2012) · Islets · doi:10.4161/isl.18262 · Cited by 10
Self-citationZeng, Q., Zou, D., Gu, S., Han, F., Cao, S., Wei, Y., & Guo, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.783078 · Cited by 9
“CDKAL1 expression in human pancreatic β-cells increases insulin secretion by inhibiting CDK5 (Li et al., 2020; Wei et al., 2005; Ubeda et al., 2006; Ching et al., 2002).”
BackgroundFurusawa, K., Asada, A., Saito, T., & Hisanaga, S. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12746 · Cited by 9
SIK2 regulates insulin secretion
Belgardt, B., & Stoffel, M. (2014) · Nature Cell Biology · doi:10.1038/ncb2925 · Cited by 9
Rabhi, N., Desevin, K., Cortez, B. N., Hekman, R. M., Lin, J. Z., Emili, A., & Farmer, S. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-99871-z · Cited by 8
Asiimwe, I. G., Walker, L. E., Sofat, R., Jorgensen, A., & Pirmohamed, M. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3229 · Cited by 8
“43 Based on the plots ( Figure S8 ) of blood glucose concentrations classified according to rs35612982 genotype and bendroflumethiazide status, wild-type homozygotes not taking thiazides have the lowest median blood glucose-levels, and display the most substantial increase in blood glucose levels…”
BackgroundWatanabe, S., Wei, F., & Tomizawa, K. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.12.001 · Cited by 9
Self-citationCaron, D., Winstall, É., Inaguma, Y., Michaud, S., Lettre, F., Bourassa, S., Kelly, I., Poirier, G. G., Faure, R. L., & Tanguay, R. M. (2008) · Journal of Proteome Research · doi:10.1021/pr8002497 · Cited by 8
Reactive Oxygen Species and Antioxidants in Pancreatic β-Cell Function – Yin and Yang
Pi, J., Zhang, Q., & Andersen, M. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_159 · Cited by 8
Muruáis, G., Lalioti, V. S., & Sandoval, I. V. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21758 · Cited by 6
“In pancreaticb-cells, high levels of glucose stimulate Cdk5 to phosphorylate Munc18 and increase Ca2þ influx in order to regulate glucose-mediated insulin exocytosis (Lilja et al., 2001, 2004; Wei et al., 2005).”
BackgroundGyan, W. R., Zhang, H., Shao, T., Yang, T., Wei, Y., Li, M., Che, X., Zeng, Q., & Guo, R. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01874-8 · Cited by 6
“The role of CDKAL1 in the association and pathogenesis of GDM may stem from its ability to regulate insulin secretion even in glucotoxic conditions [41, 42].”
Involvement of Cdk5 in Synaptic Plasticity, and Learning and Memory
Plattner, F., Giese, K.-P., & Angelo, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_16 · Cited by 6
Liang, J., Zhu, Y., Liu, X.-K., Qiu, Q. Q., Sun, Y., Wang, Y., Pei, Y., Yang, M., & Qi, L. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-109607 · Cited by 5
Liu, M.-X., Zhang, H., Liu, T., Liu, J., Zhang, L.-Q., & Zhu, J.-Z. (2025) · Diabetes and Vascular Disease Research · doi:10.1177/14791641251335923 · Cited by 4
Wang, L., Xu, W., & Wang, X. (2016) · Medicine · doi:10.1097/md.0000000000005090 · Cited by 4
Pancreatic β-Cell Senescence: Mechanisms and Association with Diabetes
Ahmed, S. M., Elshenawy, S. E., Sedky, S., Elmehrath, A. O., & El‐Badri, N. (2021) · European Medical Journal · doi:10.33590/emj/20-00128 · Cited by 5
Mohamed, M. S., Saad, Z. A., & Metwally, N. H. (2023) · ChemistrySelect · doi:10.1002/slct.202301286 · Cited by 3
Ходырев, Д. С., Nikitin, A. G., Бровкин, А. Н., Лаврикова, Е. Ю., Лебедева, Н. О., Vikulova, O. K., Шамхалова, М. Ш., Shestakova, M. V., Mayorov, M. Y., Potapov, V. A., et al. (2016) · Russian Journal of Genetics · doi:10.1134/s1022795416110065 · Cited by 4
Ocular expression of cyclin‐dependent kinase 5 in patients with proliferative diabetic retinopathy
Sano, H., Namekata, K., Niki, M., Semba, K., Murao, F., Harada, T., & Mitamura, Y. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13702 · Cited by 2
TFP5, a Peptide Derived from Cdk5 Activator p35, Protects Pancreatic β Cells from Glucose Toxicity
Liu, S.-Y., Cao, S.-L., Luo, H., Bao, L., Airaksinen, J. K. E., Li, B., Lan, X., Zhang, G.-Q., Bao, X., & Zheng, Y.-L. (2023) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-023-05959-z · Cited by 2
“Previously, Cdk5 and p35 have been identified in pancreatic islets and β cells playing an important role in insulin secretion [14].”
Yahaya, T., Oladele, E. O., Shemishere, U. B., Liman, U. U., Gomo, C. B., Abubakar, A. L., & Muhammad, B. M. (2022) · Iranian journal of diabetes and obesity · doi:10.18502/ijdo.v14i4.11233 · Cited by 2
Cdk5 as a Drug Target for Alzheimer’s Disease
Lau, L., & Hicks, C. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_18 · Cited by 2
Regulation of interferon alpha production by the MAGUK-family protein CASK under H5N1 infection
Huang, J., Sung, P., & Hsieh, S.-L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1513713 · Cited by 1
“Furthermore, CDK5 phosphorylates the L-type voltage-dependent Ca ++ channel (L-VDCC), inhibiting the exocytosis of insulin and thereby regulating glucose-stimulated insulin secretion (34).”
Stratifying high-risk prediabetes clusters using blood-based epigenetic markers
Singh, A., von Schwartzenberg, R. J., Wagner, R., Sandforth, L., Sandforth, A., Jähnert, M., Ganslmeier, M., Kabisch, S., Perakakis, N., Preissl, H. T., et al. (2026) · Biomarker Research · doi:10.1186/s40364-025-00887-8 · Cited by 2
“Upon stimulation with high glucose, CDK5 regulates the Ca 2+ influx across the membrane [44] and contributes in the microtubule disassembly in beta cells [45].”
Pharmacogenetics for T2DM and Anti-Diabetic Drugs
Huang, Q., & Liu, Z. (2011) · InTech eBooks · doi:10.5772/21229 · Cited by 1
“conditions [41].”
Kamel, E. M., Alsalamah, S. A., Khadrawy, S. M., Ahmed, N. A., Alkhayl, F. F. A., & Lamsabhi, A. M. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156234 · Cited by 1
Kodama, S., Yamada, T., Imai, J., Sawada, S., Takahashi, K., Tsukita, S., Kaneko, K., Uno, K., Ishigaki, Y., Oka, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088602 · Cited by 1
Izaola-Jáuregui, O., Primo, D., Gómez, J. J. L., & de Luis, D. A. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.017 · Cited by 1
Insulin Signaling, Epigenetics, and Human Diseases
Chruvattil, R., Belani, M., Patel, T. P., & Gupta, S. S. (2017) · Wiley eBooks · doi:10.1002/9783527697274.ch18 · Cited by 1
Cyclin-Dependent Kinase 5 and Insulin Secretion
Bark, C., Rupnik, M., Jevšek, M., Mandic, S., & Berggren, P. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_11 · Cited by 2
Navrátilová, P. (2008) · NVA (Nasjonalt vitenarkiv)
Regulation of synaptic function and plasticity by cyclin-dependent kinase 5
Su, S. C. (2012) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch6
de Sousa, A. G. P. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-18022011-161431 · Cited by 1
Genetic Control of β-Cell Mass Homeostasis
Tyrberg, B. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010011
“Another study suggests that CDK5 inhibits the function of voltage dependent calcium channels through phosphorylation [93].”
BackgroundSNAP-25 and Cdk5 as exocytotic regulators : Consequences for synaptic function and insulin release
Johansson, J. U. (2007) · Figshare
Components controlling vesicle trafficking and regulated exocytosis in pancreatic beta-cells
Mandic, S. A. (2009) · Figshare
Poulasouchidou, M., & Lambropoulos, A. F. (2010) · Aristotle University Medical journal/Aristotle University Medical Journal
Insights into the Genomic Landscape of African Ancestry Populations
Rotimi, C. N., Bentley, A. R., Doumatey, A. P., Chen, G., Shriner, D., & Adeyemo, A. (2021) · Wiley eBooks · doi:10.1002/9781119374855.ch9
Izaola-Jáuregui, O., Primo, D., Gómez, J. J. L., & de Luis, D. A. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.08.009
TFP5, a Peptide Derived From Cdk5 Activator p35, Protects Pancreatic β-Cells From Glucose ToxicityPreprint
Liu, S., Cao, S., Luo, H., Zhang, X., Bao, L., Jing, E., Li, B., Lan, X., Zhang, G., Bao, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1218842/v1
Guo, Y., Wang, Y., & Bai, B. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101554-1
(2016) · CRC Press eBooks · doi:10.1201/b19687-4
Rabhi, N., Desevin, K., Cortez, B. N., Hekman, R. M., Lin, J. Z., Emili, A., & Farmer, S. R. (2021) · Research Square · doi:10.21203/rs.3.rs-537133/v1
Guo, Y., Wang, Y., & Bai, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101554
TFP5, a Peptide Derived from Cdk5 Activator p35, Protects Pancreatic β-cells from Glucose ToxicityPreprint
Liu, S., Cao, S., Luo, H., Zhang, X., Bao, L., Jing, E., Li, B., Lan, X., Zhang, G., Bao, X., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1218842/v2
TFP5, a peptide derived from Cdk5 activator p35, protects pancreatic β-Cells from glucose toxicity
Liu, S.-Y., Cao, S.-L., Luo, H., Bao, L., Airaksinen, J. K. E., Li, B., Lan, X., Zhang, G.-Q., Bao, X., & Zheng, Y.-L. (2023) · Bulletin of Experimental Biology and Medicine · doi:10.47056/0365-9615-2023-176-7-26-34
Chinnathambi, S., Dubey, T., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.08.009
BindingDB Entry 50019728: Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery.
BindingDB (2024) · UC San Diego · doi:10.7270/q2fx7fv6
Metadata
- Authors
- Wei, F.-Y., Nagashima, K., Ohshima, T., Saheki, Y., Lu, Y.-F., Matsushita, M., Yamada, Y., Mikoshiba, K., Seino, Y., Matsui, H., & Tomizawa, K.
- Affiliations
- Okayama University (JP)
- Kyoto University (JP)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Tomizawa, Kazuhito
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-09-11
- Volume
- 11
- Issue
- 10
- Pages
- 1104-1108
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2016207732
- Cited by
- 199
- References
- 22
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 2 · 2023: 9 · 2022: 8 · 2021: 13 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 15 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 5 · 2012: 17
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- cyclin-dependent kinase 5, Cdk5/p35, glucose-stimulated insulin secretion, pancreatic beta cells, L-type voltage-dependent calcium channels, SNARE proteins, calcium influx, MIN6 cells, diabetes mellitus, hypoglycemia
- MeSH terms
- Insulin Secretion, Animals, Cell Line, Glucose, Insulin, Kinetin, Nerve Tissue Proteins, Signal Transduction, Insulin-Secreting Cells, Cyclin-Dependent Kinase 5, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.